Niki BioSolutions, Inc. (NIKI) Return on equity 2023–2025
Niki BioSolutions, Inc. (NIKI) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-5.5%FY2025 · since FY2023: -12.0% → -5.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -5.5% | +21.7 pp |
| FY2024 | -27.2% | -15.2 pp |
| FY2023 | -12.0% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More NIKI financial trends
NIKI RevenueNIKI Net incomeNIKI Net marginNIKI Gross profitNIKI Gross marginNIKI Operating incomeNIKI Operating marginNIKI Operating cash flowNIKI Free cash flowNIKI Capital expendituresNIKI Stock buybacksNIKI Dividends paidNIKI Total assetsNIKI Total liabilitiesNIKI Shareholders’ equityNIKI overview →